PharmAbs is a KU Leuven innovation, valorisation and incubation platform for the development of antibody-based therapeutics and diagnostics. PharmAbs’ expertise and technologies are used to translate basic scientific innovations emerging at universities into diagnostic/therapeutic solutions for personalized medicine that can be implemented in the clinic and/or commercialized by third parties. PharmAbs offers antibody solutions to academic groups and companies. Technology offers and licensing opportunities. PharmAbs established a structural collaboration with KU Leuven MeBios to develop integrated diagnostics and life science research tools